166 related articles for article (PubMed ID: 7734185)
1. Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex.
Mazumder A; Gupta M; Perrin DM; Sigman DS; Rabinovitz M; Pommier Y
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):115-25. PubMed ID: 7734185
[TBL] [Abstract][Full Text] [Related]
2. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.
Mazumder A; Gazit A; Levitzki A; Nicklaus M; Yung J; Kohlhagen G; Pommier Y
Biochemistry; 1995 Nov; 34(46):15111-22. PubMed ID: 7578125
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
4. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures.
Mazumder A; Neamati N; Ojwang JO; Sunder S; Rando RF; Pommier Y
Biochemistry; 1996 Oct; 35(43):13762-71. PubMed ID: 8901518
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.
Vincent KA; Ellison V; Chow SA; Brown PO
J Virol; 1993 Jan; 67(1):425-37. PubMed ID: 8416376
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of prokaryotic and eukaryotic transcription by the 2:1 2,9-dimethyl-1,10-phenanthroline-cuprous complex, a ligand specific for open complexes.
Perrin DM; Pearson L; Mazumder A; Sigman DS
Gene; 1994 Nov; 149(1):173-8. PubMed ID: 7958982
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of Escherichia coli RNA polymerase specific for the single-stranded DNA of transcription intermediates. Tetrahedral cuprous chelates of 1,10-phenanthrolines.
Perrin DM; Hoang VM; Xu Y; Mazumder A; Sigman DS
Biochemistry; 1996 Apr; 35(16):5318-26. PubMed ID: 8611519
[TBL] [Abstract][Full Text] [Related]
9. [HIV-1 integrase inhibition by dimeric bisbenzimidazoles having different spacers].
Korolev SP; Tashlitskiĭ VN; Smolov MA; Gromyko AV; Zhuze AL; Agapkina IuIu; Gottikh MB
Mol Biol (Mosk); 2010; 44(4):718-27. PubMed ID: 20873232
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.
Mazumder A; Cooney D; Agbaria R; Gupta M; Pommier Y
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5771-5. PubMed ID: 8016063
[TBL] [Abstract][Full Text] [Related]
12. Substrate features important for recognition and catalysis by human immunodeficiency virus type 1 integrase identified by using novel DNA substrates.
Chow SA; Brown PO
J Virol; 1994 Jun; 68(6):3896-907. PubMed ID: 8189526
[TBL] [Abstract][Full Text] [Related]
13. Hydroxylated aromatic inhibitors of HIV-1 integrase.
Burke TR; Fesen MR; Mazumder A; Wang J; Carothers AM; Grunberger D; Driscoll J; Kohn K; Pommier Y
J Med Chem; 1995 Oct; 38(21):4171-8. PubMed ID: 7473544
[TBL] [Abstract][Full Text] [Related]
14. Zinc stimulates Mg2+-dependent 3'-processing activity of human immunodeficiency virus type 1 integrase in vitro.
Lee SP; Han MK
Biochemistry; 1996 Mar; 35(12):3837-44. PubMed ID: 8620007
[TBL] [Abstract][Full Text] [Related]
15. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates.
Wolfe AL; Felock PJ; Hastings JC; Blau CU; Hazuda DJ
J Virol; 1996 Mar; 70(3):1424-32. PubMed ID: 8627659
[TBL] [Abstract][Full Text] [Related]
16. An essential interaction between distinct domains of HIV-1 integrase mediates assembly of the active multimer.
Ellison V; Gerton J; Vincent KA; Brown PO
J Biol Chem; 1995 Feb; 270(7):3320-6. PubMed ID: 7852418
[TBL] [Abstract][Full Text] [Related]
17. Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids.
Zhu K; Cordeiro ML; Atienza J; Robinson WE; Chow SA
J Virol; 1999 Apr; 73(4):3309-16. PubMed ID: 10074185
[TBL] [Abstract][Full Text] [Related]
18. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
[TBL] [Abstract][Full Text] [Related]
19. Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integrase.
Hazuda DJ; Wolfe AL; Hastings JC; Robbins HL; Graham PL; LaFemina RL; Emini EA
J Biol Chem; 1994 Feb; 269(6):3999-4004. PubMed ID: 8307956
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal region of HIV-1 integrase is required for integration activity, but not for DNA-binding.
Schauer M; Billich A
Biochem Biophys Res Commun; 1992 Jun; 185(3):874-80. PubMed ID: 1627142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
